Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $11.45 USD
Change Today +0.16 / 1.42%
Volume 8.1K
GNCA On Other Exchanges
As of 9:46 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

George R. Siber M.D.

Chairman of Scientific Advisory Board and Executive Director,Genocea Biosciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 82 board members in 7 different organizations across 9 different industries.

See Board Relationships


Dr. George R. Siber, M.D., serves as Chief Scientific Officer of ClearPath Development Company. Dr. Siber served as the Chief Scientific Officer and Executive Vice President of Wyeth Vaccines, Ltd. Dr. Siber oversaw the development and approval of multiple widely-used childhood vaccines including an acellular pertussis vaccine (Acel-Imune), a meningococcal meningitis vaccine (Meningitec), and a pneumococcal vaccine (Prevnar). He served as Associate Professor of Medicine ...

Read Full Background

Corporate Headquarters*

100 Acorn Park Drive
Cambridge, Massachusetts 02140

United States

Phone: 617-876-8191
Fax: --

Board Members Memberships*

Director and Member of Scientific Advisory Board
Chairman of Scientific Advisory Board and Executive Director


McGill University
Unknown/Other Education
Bishop's University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$156,006
Total Calculated Compensation$156,006
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNCA:US $11.45 USD +0.16


Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Corporate Secretary and Director
GenVec, Inc.
Philippe Archinard Ph.D.Chairman and Chief Executive Officer
Transgene SA
Kalevi Reijonen M.D.Chief Executive Officer and President
FIT Biotech Oy
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOCEA BIOSCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at